NCT02022618View on ClinicalTrials.gov

Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects

CompletedOBSERVATIONAL
Enrollment

454

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Hypertension
Trial Locations (1)

37003

La Alamedilla Health center, Salamanca

All Listed Sponsors
lead

Fundacion para la Investigacion y Formacion en Ciencias de la Salud

OTHER

NCT02022618 - Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects | Biotech Hunter | Biotech Hunter